Hyaluronic acid-based biopharmaceutical delivery and tumor-targeted drug delivery system

被引：262
|
作者：
Huang, Gangliang [1 ]
Huang, Hualiang [2 ]
机构：
[1] Chongqing Normal Univ, Act Carbohydrate Res Inst, Chongqing 401331, Peoples R China
[2] Wuhan Inst Technol, Sch Chem & Environm Engn, Wuhan 430073, Hubei, Peoples R China
来源：
JOURNAL OF CONTROLLED RELEASE | 2018年 / 278卷
关键词：
Hyaluronic acid; Carrier; Sustained release; Biopharmaceutical delivery; Tumor-targeted drug delivery; RELEASE FORMULATION; PACLITAXEL DELIVERY; SUSTAINED-RELEASE; NANOPARTICLES; SIRNA; CONJUGATE; LIPOSOMES; LUNG; DERIVATIVES; RESISTANCE;
D O I：
10.1016/j.jconrel.2018.04.015
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
Hyaluronic acid (HA) is a natural polysaccharide with good biocompatibility and degradability. HA and its derivatives can be used as sustained-release carriers for drugs, which can delay the release of drugs and have a long-acting effect. They can be used for the delivery of various drugs such as proteins, nucleic acids and antitumor drugs. HA and its derivatives can specifically bind to multiple receptors on the cell surface and can be used for targeted drug delivery, especially for the delivery of anti-tumor drugs. Thus, there are different forms of tumor-targeted drug delivery systems based on HA.
引用
收藏
页码：122 / 126
页数：5
相关论文
共 50 条
  • [31] Cubosomes: Design, Development, and Tumor-Targeted Drug Delivery Applications
    Umar, Hassaan
    Wahab, Habibah A.
    Gazzali, Amirah Mohd
    Tahir, Hafsa
    Ahmad, Waqas
    POLYMERS, 2022, 14 (15)
  • [32] pH sensitive polymeric complex of cisplatin with hyaluronic acid exhibits tumor-targeted delivery and improved in vivo antitumor effect
    Fan, Xiaohong
    Zhao, Xuesong
    Qu, Xinkai
    Fang, Jun
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 496 (02) : 644 - 653
  • [33] Improved anti-tumor activity and safety profile of a paclitaxel-loaded glycyrrhetinic acid-graft-hyaluronic acid conjugate as a synergistically targeted drug delivery system
    Zhang Li
    Zhou Jian-Ping
    Yao Jing
    CHINESE JOURNAL OF NATURAL MEDICINES, 2015, 13 (12) : 915 - 924
  • [34] Application of Chitosan-Based Nanocarriers in Tumor-Targeted Drug Delivery
    Ghaz-Jahanian, Mohammad Ali
    Abbaspour-Aghdam, Farzin
    Anarjan, Navideh
    Berenjian, Aydin
    Jafarizadeh-Malmiri, Hoda
    MOLECULAR BIOTECHNOLOGY, 2015, 57 (03) : 201 - 218
  • [35] Exosomes separated based on the "STOP'' criteria for tumor-targeted drug delivery
    Qi, Hongzhao
    Yang, Lijun
    Li, Xueping
    Zhan, Qi
    Han, Donglin
    Zhao, Jin
    Hou, Xin
    Yuan, Xubo
    JOURNAL OF MATERIALS CHEMISTRY B, 2018, 6 (18) : 2758 - 2768
  • [36] Advances in aggregatable nanoparticles for tumor-targeted drug delivery
    Wenqi Yu
    Maxim Shevtsov
    Xianchun Chen
    Huile Gao
    ChineseChemicalLetters, 2020, 31 (06) : 1366 - 1374
  • [37] Advances in aggregatable nanoparticles for tumor-targeted drug delivery
    Yu, Wenqi
    Shevtsov, Maxim
    Chen, Xianchun
    Gao, Huile
    CHINESE CHEMICAL LETTERS, 2020, 31 (06) : 1366 - 1374
  • [38] Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review
    Nader Salari
    Kamran Mansouri
    Elahe Valipour
    Farzaneh Abam
    Mehdi Jaymand
    Shna Rasoulpoor
    Sadat Dokaneheifard
    Masoud Mohammadi
    DARU Journal of Pharmaceutical Sciences, 2021, 29 : 439 - 447
  • [39] Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect
    Maeda, H.
    Bharate, G. Y.
    Daruwalla, J.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2009, 71 (03) : 409 - 419
  • [40] Recent Advances of Poly(lactic-co-glycolic acid)-Based Nanoparticles for Tumor-Targeted Drug Delivery
    Jiang, Linye
    Luo, Jie
    Hong, Dawei
    Guo, Shuhong
    Wang, Shuyi
    Zhou, Bizhong
    Zhou, Shiyu
    Ge, Jingyan
    CHEMISTRYSELECT, 2022, 7 (03):
12345